As pharma companies increasingly invest in the development of biologics, it’s important to incorporate full service support and adherence programs into go to market strategies. Great patient support and adherence programs enhance and often drive improved patient quality and length of life. If patients find therapies too expensive, complex or invasive they are not likely…